Rockefeller Capital Management
RGNX icon

Rockefeller Capital Management’s Regenxbio RGNX Stock Holding History

Rockefeller Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264K Buy
31,502
+3,782
+14% +$39.7K ﹤0.01% 2328
2025
Q4 		$399K Buy
27,720
+947
+4% +$11.8K ﹤0.01% 2019
2025
Q3 		$258K Hold
26,773
– – ﹤0.01% 2096
2025
Q2 		$220K Buy
+26,773
New +$224K ﹤0.01% 1703
2025
Q1 		– Sell
-27,108
Closed -$210K – 1727
2024
Q4 		$210K Sell
27,108
-13,864
-34% -$130K ﹤0.01% 1648
2024
Q3 		$430K Buy
40,972
+17
+0% +$207 ﹤0.01% 1469
2024
Q2 		$479K Sell
40,955
-16
-0% -$249 ﹤0.01% 1443
2024
Q1 		$863K Sell
40,971
-81
-0.2% -$1.44K ﹤0.01% 1311
2023
Q4 		$737K Buy
41,052
+155
+0.4% +$2.73K ﹤0.01% 1243
2023
Q3 		$673K Hold
40,897
– – ﹤0.01% 1218
2023
Q2 		$818K Hold
40,897
– – ﹤0.01% 1167
2023
Q1 		$773K Buy
40,897
+40,662
+17,303% +$900K ﹤0.01% 1171
2022
Q4 		$5K Sell
235
-300
-56% -$6.78K ﹤0.01% 3340
2022
Q3 		$14K Sell
535
-450
-46% -$13.3K ﹤0.01% 2942
2022
Q2 		$24K Buy
985
+250
+34% +$6.25K ﹤0.01% 2643
2022
Q1 		$24K Hold
735
– – ﹤0.01% 2644
2021
Q4 		$24K Hold
735
– – ﹤0.01% 2563
2021
Q3 		$30K Hold
735
– – ﹤0.01% 2399
2021
Q2 		$28K Hold
735
– – ﹤0.01% 2332
2021
Q1 		$25K Buy
735
+235
+47% +$10K ﹤0.01% 2188
2020
Q4 		$22K Hold
500
– – ﹤0.01% 1970
2020
Q3 		$13K Buy
+500
New +$16.3K ﹤0.01% 1943
2019
Q2 		– Sell
-100
Closed -$6K – 1911
2019
Q1 		$6K Buy
+100
New +$4.95K ﹤0.01% 1601

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Capital Management's RGNX Position: Q1 2026 in Review

Rockefeller Capital Management increased its Regenxbio (RGNX) stake by 14% in Q1 2026, buying an estimated $39.7K and bringing the position to 31,502 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Rockefeller Capital Management first reported a position in RGNX in Q1 2019 and has held it in 23 quarters since. The position peaked at $863K in Q1 2024. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Rockefeller Capital Management held 31,502 shares of Regenxbio worth $264K as of Q1 2026.
  • Rockefeller Capital Management bought 3,782 Regenxbio shares in Q1 2026, an estimated $39.7K.
  • Regenxbio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2328 holding.
  • Rockefeller Capital Management first reported a position in Regenxbio in Q1 2019 and has held it in 23 quarters since.
  • Rockefeller Capital Management's Regenxbio position peaked at $863K in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.